Density: Approximately 1.60 ± 0.1 g/cm³ (predicted)
Purity: ≥98%
Physical and Chemical Properties
Solubility: Soluble in DMF at 30 mg/ml, DMSO at 14 mg/ml, Ethanol at 5 mg/ml, and PBS (pH 7.2) at 5 mg/ml
Water Solubility: Soluble in water at 5 mg/ml
Form: Crystalline solid
Color: White to off-white
Storage Conditions
Should be sealed under dry conditions and stored in a refrigerator at -20°C
Safety and Hazards
Eptifibatide may pose certain hazards, and therefore, appropriate safety procedures should be followed during use or handling
Specific hazard symbols, precautionary statements, and safety measures are outlined in the relevant Safety Data Sheet (SDS)
Applications
Eptifibatide is a novel polypeptide platelet glycoprotein IIb/IIIa receptor antagonist that inhibits platelet aggregation and thrombus formation by blocking the final common pathway of platelet aggregation. It has proven therapeutic benefits in the interventional treatment of acute coronary syndromes. Additionally, Eptifibatide can be used in other conditions or diseases requiring antiplatelet therapy.
